Successful Split Liver-Kidney Transplant for Factor H Associated Hemolytic Uremic Syndrome

Jeffrey M. Saland, Benjamin L. Shneider, Jonathan S. Bromberg, Patricia A. Shi, Stephen C. Ward, Margret S. Magid, Corinne Benchimol, Mouin G. Seikaly, Sukru Emre, Elena Bresin,

Clinical Journal of the American Society of Nephrology · 2008 · 63 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND AND OBJECTIVES: A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report. RESULTS: Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr. CONCLUSIONS: This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.

References

31